Time courses and value of circulating microparticles in patients with operable stage non-small cell lung cancer undergoing surgical intervention-Reference-Cited by-同舟云学术

Time courses and value of circulating microparticles in patients with operable stage non-small cell lung cancer undergoing surgical intervention

Published:2016-04-08 Issue:9 Volume:37 Page:11873-11882
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Tseng Chia-Cheng,Wang Chin-Chou,Hsiao Chang-Chun,Lu Hung-I,Leu Steve,Chang Huang-Chih,Huang Kuo-Tung,Fang Wen-Feng,Chen Yu-Mu,Liu Shih-Feng,Yang Cheng-Ta,Lin Meng-Chih,Yip Hon-Kan

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-016-5047-5.pdf

Reference38 articles.

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96.

2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: Globocan 2008. Int J Cancer. 2010;127:2893–917.

3. Tartour E, Zitvogel L. Lung cancer: potential targets for immunotherapy. Lancet Respir Med. 2013;1:551–63.

4. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83:584–94.

5. Silvestri GA, Tanoue LT, Margolis ML, Barker J, Detterbeck F, American College of Chest Physicians. The noninvasive staging of non-small cell lung cancer: the guidelines. Chest. 2003;123:147S–56S.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular Dust as a Novel Hope for Regenerative Cancer Medicine;Advances in Experimental Medicine and Biology;2020

2. Metabolomics workflow for lung cancer: Discovery of biomarkers;Clinica Chimica Acta;2019-08

3. Extracellular Vesicles: Mechanisms in Human Health and Disease;Antioxidants & Redox Signaling;2019-02-20

4. Clinical significance of circulating microparticles in Ph− myeloproliferative neoplasms;Oncology Letters;2017-06-22

5. Circulating microparticles are prognostic biomarkers in advanced non-small cell lung cancer patients;Oncotarget;2017-06-06